Health Care & Life Sciences » Biotechnology | Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
97.00
106.00
87.00
77.00
85.00
110
Gross Income
97.00
106.00
87.00
77.00
85.00
110
SG&A Expense
4,921.00
7,315.00
8,449.00
5,006.00
4,914.00
13,953
EBIT
5,018.00
7,421.00
8,536.00
5,083.00
4,999.00
14,063
Non Operating Income/Expense
-
1,825.00
-
-
-
-
Pretax Income
4,874.00
9,246.00
8,488.00
4,982.00
4,952.00
13,948
Income Tax
25.00
-
-
-
-
-
Consolidated Net Income
4,899.00
9,246.00
8,488.00
4,982.00
4,952.00
13,948
Net Income
4,899.00
9,246.00
8,488.00
4,982.00
4,952.00
13,948
Net Income After Extraordinaries
4,899.00
9,246.00
8,488.00
4,982.00
4,952.00
13,948
Net Income Available to Common
4,899.00
9,246.00
8,488.00
4,982.00
4,952.00
13,948
EPS (Basic)
0.46
0.68
0.46
0.27
0.26
0.70
Basic Shares Outstanding
10,738.10
13,662.80
18,405.60
18,663.20
18,777.30
19,997.70
EPS (Diluted)
0.46
0.68
0.46
0.27
0.26
0.70
Diluted Shares Outstanding
10,738.10
13,662.80
18,405.60
18,663.20
18,777.30
19,997.70
EBITDA
4,921.00
7,315.00
8,449.00
5,006.00
4,914.00
13,953
Non-Operating Interest Income
144.00
-
48.00
101.00
47.00
115

About Brainstorm Cell Therapeutics

View Profile
Address
1325 Avenue of Americas
New York New Jersey 10019
United States
Employees -
Website http://www.brainstorm-cell.com
Updated 07/08/2019
Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops and commercializes adult stem cell therapeutic products. It focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury. The company was founded on September 22, 2000 and is headquartered in New York, NJ.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.